Filing Flows › Organogenesis Holdings (ORGO) › Stock forecast & fair value
Organogenesis Holdings (ORGO) stock forecast and price target
Organogenesis Holdings (ORGO) trades at $0.81. One analyst's price target is $2.00 (+146%).
Organogenesis Holdings' latest quarter
Organogenesis Holdings, Q3 2026: revenue $45.5M (-70% year over year), operating margin -64.9%, net loss $29.6M, operating cash flow −$18.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ORGO stock?
One analyst's 12-month target is $2.00, +146% from $0.81. The average rating is none.
Does Organogenesis Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is ORGO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.